Axovant Gene Therapies Ltd (NASDAQ:AXGT)

4.43
Delayed Data
As of Jan 17
 -0.22 / -4.73%
Today’s Change
3.81
Today|||52-Week Range
19.60
-13.48%
Year-to-Date
No recent news for Axovant Gene Therapies Ltd.

Today’s Trading

Previous close4.65
Today’s open4.66
Day’s range4.43 - 4.77
Volume231,620
Average volume (3 months)153,005
Market cap$103.0M
Data as of 3:59pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)+51.36%
Earnings growth (this year)+61.81%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
SCPHscPharmaceuticals In...-0.20-3.57%
SESNSesen Bio Inc-0.03-2.98%
ASRTAssertio Therapeutic...+0.03+2.48%
AVEOAveo Pharmaceuticals...-0.02-3.12%
Data as of 4:00pm ET, 01/17/2020

Financials

Next reporting dateFebruary 6, 2020
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$0.00
Annual profit (last year)-$129.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
London, London & South East

Forecasts